# Intuitive Surgical Inc. (ISRG) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Medical Devices & Supplies. Price $440.75, market value $155.7 billion.

## Valuation
- **P/E (trailing): 53.3×** (5-yr avg 74.0×, 3-yr avg 73.4×). Intuitive Surgical Inc. trades at 53.3× trailing earnings, well below its own five-year average of 74.0×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 35.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.57**. A PEG of 1.57 is in the range usually read as fairly priced for its growth.
- **Price / sales: 13.4×**. Each dollar of revenue is priced at 13.4×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 9.6×**. The shares trade at 9.6× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 2.3%** (5-yr avg 1.0%). Free cash flow equals 2.3% of the market value, above its five-year average of 1.0%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 1.9%**. The inverse of the P/E: 1.9% of the price is earned each year.

## Profitability
- **Gross margin: 67.2%**. Intuitive Surgical Inc. keeps 67.2% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 28.4%**. 28.4% of revenue is left after running the business, an exceptional level.
- **Net margin: 28.4%**. 28.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 16.0%**. 16.0% on shareholders' equity is solid.
- **Return on assets: 14.5%**. Each dollar of assets produces 14.5% of profit.

## Growth
- **Revenue growth (1 yr): 20.5%** (3-yr 17.4%/yr, 5-yr 18.2%/yr). Revenue grew 20.5% over the last year, against 18.2% a year compounded over five years.
- **EPS growth (1 yr): 22.6%** (3-yr 29.2%/yr, 5-yr 21.8%/yr). Earnings per share rose 22.6%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 37.5%/yr**. Free cash flow has compounded at 37.5% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Current ratio: 4.87** (quick 4.87). Current assets cover the next year's liabilities 4.87 times.
- **Altman Z-score: 39.76**. A Z-score of 39.76 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Intuitive Surgical Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (30 analysts). 30 analysts cover Intuitive Surgical Inc.; the consensus is buy, with an average price target of $482.63 (+10% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -18.2%** (YTD -22.9%, 3-mo 16.4%). The shares are down 18.2% over twelve months including dividends.
- **From 52-week high: -27.0%** (34.1% above the low). Trading 27% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 57**. An RSI of 57 is neutral.
- **Beta (1 yr): 0.90** (volatility 34%). Beta of 0.90 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ISRG · Page: https://foliofundamentals.com/stocks/isrg

Not investment advice.